12:00 AM
 | 
Jan 10, 2000
 |  BC Week In Review  |  Company News  |  Deals

Algos, Cambridge NeuroScience deal

CNSI received a non-exclusive license to three ALGO patents covering the use of NMDA ion channel blockers to treat pain either as monotherapy or...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >